Table 6.

Medians and ranges (min–max) for various serum biochemical parameters for the control population and subgroups of the study population. Also shown is the number of cats with results outside the reference interval for each subgroup

Cats	ALT (U/L)	AST (U/L)	P (mg/dL)	ALB (g/dL)	fPLI (μg/L)
Group (N) (S/A)	Median (Range) (n)	Median (Range) (n)	Median (Range) (n)	Median (Range) (n)	Median (Range) (n)
Ctrl (8) (0/8)	35.5a (25–58) (0)	21.5a (15–32) (0)	5.7a (5.1–6.7) (0)	3.9a (3.2–3.9) (0)	1.5a (1.3–1.8) (0)
IBD (13) (8/5)	47.0a,b (24–283) (3)	26.0a,b (16–174) (1)	5.5a,b (3.3–7.5) (2)	3.7a,b (2.6–4.5) (1)	1.7a,c (1.2–45) (2)
Ch (6) (2/4)	39.0a (23–180) (1)	25.5a,b (20–135) (1)	5.0b (4.5–6) (0)	3.4b (3.2–3.8) (0)	4.2b (1.6–6.6) (4)
IBD+Ch (16) (6/10)	32.0a (14–710) (4)	33.0a,b (15–70) (0)	5.0b (4–8) (1)	3.5b (2.8–3.9) (1)	1.9a,c (1.2–18.5) (3)
IBD+Ch+P (8) (8/0)	68.0b (48–210) (3)	52.0b (31–87) (0)	4.2c (3.4–6.4) (1)	3.5b (2.3–4.4) (3)	2.0c (1.5–4.0) (1)
Reference interval	21–103	15–97	3.5–6.7	3–4.8	0–3.5
MSSDO0.05	29.0	30.5	0.7	0.4	0.5
Kruskal‐Wallis P	.026	.068	.064	.098	.022

MSSDO: minimum statistically significant difference observed at a significance level P = .05

a, b, c: in the same column of the table, medians followed by common letter do not differ significantly, according to the results of a series of Mann‐Whitney tests. Statistically significant differences exist between medians followed by different superscript letters.

Ctrl: controls

IBD: cats with histopathological evidence of idiopathic inflammatory bowel disease

Ch: cats with histopathological evidence of cholangitis

IBD+Ch: cats with histopathological evidence of IBD and cholangitis

IBD+Ch+P: cats with histopathological evidence of IBD, cholangitis, and pancreatitis

S/A: symptomatic/asymptomatic cats in each subgroup

ALT: alanine transaminase

AST: aspartate transaminase

P: phosphorus

ALB: albumin

fPLI: feline pancreatic lipase immunoreactivity concentration (as measured by Spec fPL^®).